HORIBA Medical has obtained CE-mark certification for the Microsemi CRP LC-767G, its new generation of the Microsemi CRP haematology analyser.
The Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity, providing higher memory, usability plus a new parameter (granulocytes-to-lymphocytes ratio [GLR]). The robustness and ease of use of the Micros range are improved for this new generation analyser.
After a highly successful release in Japan, this new instrument is now available in Europe. This compact, easy-to-use addition to the Micros range, simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18 µL of blood – all in just four minutes.
The Microsemi CRP LC-767G provides information of great clinical value enabling quicker and more accurate medical decisions at the point of care to reduce hospitalisation times and patient costs. Its powerful and accurate CRP analysis allows the screening of patient samples to quantify the presence of inflammation caused by bacterial, viral, parasite infections and other treatable inflammatory diseases. Also, the simultaneous access to lymphocytes, GLR and CRP provided on this analyser is very helpful for COVID-19 patient screening, monitoring and triage. Measurement is possible immediately after capillary blood sample collection, making this analyser the ideal choice for emergency testing situations.
This new Microsemi CRP LC-767G can also be used to assess infection and inflammatory conditions that require progressive observation. Furthermore, its micro-sampling capabilities are ideal for paediatric blood analysis, at the point of care, requiring just 10 µL for CBC and 18 µL for CBC+CRP, and can be used with capillary as well as venous blood samples.
